(19)
(11) EP 3 164 120 A2

(12)

(88) Date of publication A3:
24.03.2016

(43) Date of publication:
10.05.2017 Bulletin 2017/19

(21) Application number: 15815948.3

(22) Date of filing: 09.07.2015
(51) International Patent Classification (IPC): 
A61K 9/70(2006.01)
(86) International application number:
PCT/US2015/039831
(87) International publication number:
WO 2016/004443 (07.01.2016 Gazette 2016/01)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 03.07.2014 US 201461998622 P
03.07.2014 US 201461998623 P
03.07.2014 US 201461998624 P
07.07.2014 US 201461998683 P
09.07.2014 US 201461998788 P
09.07.2014 US 201461998790 P
01.08.2014 US 201461999589 P
02.02.2015 US 201562125837 P
06.07.2015 WO PCT/US2015/039236
06.07.2015 WO PCT/US2015/039264
06.07.2015 WO PCT/US2015/039268
06.07.2015 WO PCT/US2015/039272

(71) Applicant: BKR IP HOLDCO LLC
Broomall, PA 19008 (US)

(72) Inventor:
  • REDDING, Bruce, K., Jr.
    Broomall, PA 19008 (US)

(74) Representative: Zech, Stefan Markus et al
Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB Postfach 86 06 24
81633 München
81633 München (DE)

   


(54) MODIFICATION OF PHARMACEUTICAL PREPARATIONS TO MAKE THEM MORE CONDUCIVE TO ULTRASONIC TRANSDERMAL DELIVERY